Company Filing History:
Years Active: 2023
Title: Ji In Jung: Innovator in Bacteriophage Research
Introduction
Ji In Jung is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, specifically through his work on bacteriophages, which are viruses that infect and kill bacteria. His research has important implications for treating bacterial infections and advancing medical science.
Latest Patents
Ji In Jung is credited with a patent for the Myoviridae bacteriophage Aer-HYP-3 (Accession number: KCTC 13479BP). This bacteriophage demonstrates a remarkable ability to eliminate bacteria, making it a powerful tool for preventing and treating diseases caused by bacterial infections. The patent details the genome of this bacteriophage, represented by SEQ ID NO: 1, and describes a methodology for using a composition containing Aer-HYP-3 as an active ingredient in therapeutic applications.
Career Highlights
Ji In Jung is affiliated with Intron Biotechnology, Inc., where he continues his innovative research and development efforts. His expertise in bacteriophage technology positions him at the forefront of efforts to tackle bacterial resistance and improve therapeutic strategies. The impact of his work is particularly relevant in today’s context of rising antibiotic resistance.
Collaborations
Throughout his career, Ji In Jung has collaborated with esteemed colleagues, including Seong Jun Yoon and Soo Youn Jun. These partnerships are vital for the advancement of research and development in biotechnology, allowing for a multidisciplinary approach to solving complex health problems related to bacterial infections.
Conclusion
In summary, Ji In Jung stands out as an influential inventor and researcher, particularly in the area of bacteriophage technology. His patent contributes to ongoing efforts to combat bacterial diseases and highlights the potential of innovative solutions in biotechnology. As his work continues to develop, it promises to play a crucial role in improving public health outcomes.